Skip to content

Clinical trials

Phase 4 Inflammation trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 4 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20142
20161
20172
20201
20211
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status4
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital2
Dongying Zhang1
Kunyue Li1
Novartis Pharmaceuticals1
Ocumension Therapeutics (Shanghai) Co., Ltd1
Peking University First Hospital1
Sun Yat-sen University1
Taizhou Fourth People's Hospital1
The First Affiliated Hospital with Nanjing Medical University1
Zhongshan Ophthalmic Center, Sun Yat-sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation11
Pain2
Agnosia1
Angina, Stable1
Autoimmune Diseases1
Carcinoma, Hepatocellular1
Carotid Stenosis1
Cataract1
Coronary Artery Disease1
Dry Eye Syndromes1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.